Two brands of potassium chloride capsules are being recalled because they may not dissolve as they should, which could cause a person to have a heart attack, according to the Food and Drug ...

Two brands of potassium chloride extended-release capsules are being recalled because they might not dissolve, posing a threat of cardiac arrest. Glenmark Laboratories recalled 114 batches of ...

At this time, there have been no reports of injury related to this recall. Glenmark Pharmaceuticals is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750mg) 10 mEq K ...

The next step is to add potassium chloride, which is sourced from the grocery store as a sodium-free salt alternative. After mixing with the filtered remains of the bleach reaction the two are ...

A total of 135 batches of potassium chloride capsules have been recalled because the extended release capsules might not release. Glenmark Laboratories recalled 114 batches of 750 mg Potassium ...

Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Esophageal compression due to ...

(RTTNews) - Mahwah, New Jersey-based Glenmark Pharmaceuticals Inc., USA is recalling 114 batches of Potassium Chloride Extended-Release Capsules USP (750 mg) 10 mEq K citing failed dissolution ...

Trading Advisories, Courses & Webinars by Top Verified Experts. Unlock Your Trading Potential: Trade like Experts with SEBI registered creators, Learn from Courses & Webinars by India's Finest ...

This leaflet answers some common questions about MOLAXOLE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in ...